Loading data...
Loading data...
Analyzing the stock…
70
Gathering technical, fundamental, and market data — a few seconds
Industrials · ·
$131.50
▼ $1.26 (-0.9%)
Market data updated: 09/22 06:35 AM
Fundamentals updated: 09/22/2026
News analyzed: 09/22/2026
Market Cap
$3.81B
Day Range
$130.01 - $132.90
52-Week Range
$112.09 - $204.00
Beta
—
Next Earnings
15.10.2026
Support
$120.59
Resistance
$155.18
BMI is a stock from the Industrials sector — Manufacturing, aerospace, defense, and infrastructure — closely tied to capital-investment cycles and economic growth.
-25.7% (1Y)
Strengths: 18/31 factors positiveRisk: Medium
This score and all analysis on this page are for informational and educational purposes only and do not constitute investment advice. Read the full disclaimer
Weighted: Technical 25% · Fundamental 20% · Growth 15% · Valuation 15% · News 10% · Quality 10% · Risk 5%
Overall Score
🟡 Mixed
Technical Trend
🟡 Mixed
Insiders
🟢 Bullish
Computed directly from the same signals behind the score above — not AI-generated.
Biggest positive driver
Operating margin stability
Operating margin is stable or improving over time
Quality
Biggest negative driver
Calmar Ratio (return vs. drawdown)
Calmar: -0.09 (3y annualized return -4.8% / max drawdown 55.4%)
Risk
What to watch next
When today echoes the past.
NO RELIABLE ECHO FOUND
Only 2 historical analog(s) found after removing overlapping dates — too few for a statistically meaningful comparison.
Historical matches considered: 2
TIME ECHO identifies historical situations that resemble the current market state. Historical outcomes are not guarantees of future performance. Similarity does not imply causation, and results may change as new data becomes available.
🗓️ What Changed This Week
🌱 Building History
We don't have a real data point from a week ago for this stock yet. The weekly comparison will appear once enough history has accumulated.
📊 Score History
65
Today
—
30D
—
90D
—
1Y
🐂🐻 Investment Thesis
🐂 Bull Case
🐻 Bear Case
🔍 What Could Prove This Wrong
This isn't a price-direction forecast — just a synthesis of real, already-computed data, and future conditions that could change the picture.
🕰️ StockIQ Time Machine
What did StockIQ know — and when? Pick a date from the real accumulated history.
As of August 29, 2026
Then
71
$135.61
Now
65
$131.50
What happened since
Signals detected by this date
No signals detected by this date
🧬 STOCK DNA
This stock's profile across 8 real dimensions — a research tool, not a recommendation
Growth
70
Quality
63
Value
50
Momentum
49
Risk
54
Sentiment
100
Fundamental
80
Institutional
100
Stocks with a similar DNA right now
This stock hasn't been analyzed by StockIQAI's movement engine yet — coverage is still expanding. Check back soon.
Recent media coverage of Badger Meter, Inc. (BMI) has primarily focused on its strong financial fundamentals and investor appeal, particularly as a dividend-paying stock. Analysts highlight its consistent growth, high return on invested capital (47%), zero debt, and robust cash flow, positioning it as a durable, cash-producing company. However, some reports note its valuation as relatively rich, raising questions about whether it is fairly valued ahead of upcoming earnings. The company is also mentioned alongside other dividend growth stocks in September.
AI summary based on English-language news sources only — not investment advice.
Everyone's writing about Badger Meter, Inc.. News trend score: 100. Reason: 14 of the last 20 articles are positive, versus 1 negative.
News trend analysis is based on article sentiment only, and is not investment advice or financial counsel. Read the full disclaimer
🌡️ Emotional Temperature
17
🎯 Conviction (vs. Emotion)
42
Psychology
18
Fundamentals
80
Technical
49
Valuation
50
Price, volume, and sentiment accelerating together — a sign investors are chasing the price, not just following it.
Extreme momentum, price far above its moving average, and a large premium over fair value.
A sharp drop, unusual volume, and negative news sentiment all at once — selling pressure that looks emotional.
The price rise has far outpaced the actual improvement in fundamental data.
The stock is moving in lockstep with its peers at the same intensity, rather than on its own data.
Price (3M)
+3%
Market Narrative
61
Fundamental Reality
42
Narrative Gap
+19
🔀 Psychology Acceleration
News attention/sentiment is running well ahead of the price move itself.
🧠 StockIQ Psychologist
The market behavior for BMI suggests euphoria as the dominant psychological state, driven by a 5% premium over DCF fair value and extreme positive sentiment (98/100). Overconfidence is also present, as price momentum (+1.2%) exceeds fundamental growth (+0.1% EPS), indicating investors may be overestimating near-term gains. The narrative gap (21 points) hints at a disconnect between market enthusiasm and underlying fundamentals, raising the question of whether this premium is sustainable. The absence of panic or herding signals further supports a bullish, overoptimistic sentiment. Key uncertainty remains: can momentum sustain itself beyond short-term momentum-driven buying?
Updated: 09/06/2026, 02:05 AM
What could change this?
👥 What the crowd believes
"Dividend Champion, Contender, And Challenger Highlights (SeekingAlpha, Article 1)"
"47% ROIC, zero debt, and high cash conversion (ChartMill, Article 5)"
"valuation is rich (ChartMill, Article 5)"
"Technological Advancements Fueling Badger Meter’s (BMI) Long-Term Growth Potential (Insider Monkey, Article 12)"
📈 5D Investor Psychology
Signal classification confidence: High (confidence in the behavioral read, not a price prediction). Describes observable market behavior, not what any individual investor thinks, and is not a buy/sell signal.
🏛️ Investor DNA — Historical Investors
A Historical Strategy Simulation: assuming each investor follows their documented principles, how would they rate this stock today? This is not a prediction of what they would actually do.
🟢 Best match
Walter Bagehot — 100/100
🔴 Weakest match
Benjamin Graham (Enterprising Investor) — 31/100
🗣️ Why do they disagree?
The stark divide in verdicts for BMI reflects a clash between growth-oriented and defensive investment philosophies. Methodologies like Walter Bagehot’s focus on liquidity and survival in crises—scoring it a near-perfect 100—highlight its resilience, while Thorstein Veblen and Edgar Lawrence Smith’s high scores (84 and 82) suggest it aligns with long-term value creation and buy-and-hold potential. In contrast, Benjamin Graham’s strict valuation frameworks (scoring it 31–36) dismiss it as statistically unappealing, even for his more aggressive Enterprising Investor criteria, signaling a disconnect between traditional margin-of-safety principles and the stock’s perceived fundamentals. Meanwhile, traders like Jesse Livermore (40) and Jack Schwager (23) reject it outright due to perceived trend resistance or lack of technical setup, while Peter Lynch (39) and Philip Fisher (61) remain lukewarm, questioning whether its growth justifies its valuation. The middle-ground approaches—Howard Marks’ caution (61) and the efficient-market skeptics (48)—reflect uncertainty over whether the stock’s strengths outweigh its risks or if it’s simply a market-neutral play.
Walter Bagehot
Lombard Street (1873)
🟢 100
Strong liquidity — would likely survive a real credit squeeze
Key question
Does this company have enough liquidity to survive real stress?
Fact → Principle → Simulation
Thorstein Veblen
The Theory of Business Enterprise (1904)
🟢 84
Growth appears aligned with real value creation
Key question
Is management building real value, or just building itself?
Fact → Principle → Simulation
Edgar Lawrence Smith
Common Stocks as Long-Term Investments (1924)
🟢 82
Looks like a real 'buy and hold for a decade' candidate
Key question
Is this a stock I'd be happy to hold and forget about for a decade?
Fact → Principle → Simulation
Charles Mackay
Extraordinary Popular Delusions and the Madness of Crowds (1841)
🟢 75
No obvious signs of crowd mania
Key question
Am I being swept along with the crowd, or thinking for myself?
Fact → Principle → Simulation
Morgan Housel
The Psychology of Money (2020)
🟢 72
The kind of quiet compounder a patient holder could actually stick with
Key question
Could I live with this volatility long enough for compounding to actually work?
Fact → Principle → Simulation
Gerald M. Loeb
The Battle for Investment Survival (1935)
🟢 66
Reasonable capital-preservation profile
Key question
How much capital could I lose here if I'm wrong?
Fact → Principle → Simulation
Howard Marks
The Most Important Thing (2011) / Mastering the Market Cycle (2018)
🟢 65
Risk appears reasonably priced — no obvious cycle-timing red flag
Key question
What is the market probably misunderstanding about the risk here?
Fact → Principle → Simulation
Philip Fisher
Common Stocks and Uncommon Profits (1958)
🟡 61
Solid, but not the exceptional quality Fisher looked for
Key question
How exceptional is this business, really?
Fact → Principle → Simulation
Jack Schwager
Market Wizards (1989)
🟡 54
No clear edge either way
Key question
What's the risk/reward here, and where is my exit point?
Fact → Principle → Simulation
Burton Malkiel & John Bogle
A Random Walk Down Wall Street (1973) / The Little Book of Common Sense Investing (2007)
🟡 51
Mixed case — the evidence for picking this stock over an index is not strong
Key question
Do I actually have an edge here, or do I just think I do?
Fact → Principle → Simulation
Howard Marks (Market Cycle)
Mastering the Market Cycle (2018)
🟡 50
Somewhere in the middle of the cycle
Key question
Where are we in the cycle right now — near a hot extreme, or a cold one?
Fact → Principle → Simulation
Samuel Armstrong Nelson
The ABC of Stock Speculation (1903)
🟡 47
Mid-cycle — no strong signal either way
Key question
Is the price overextended, or is there still room to move?
Fact → Principle → Simulation
Peter Lynch
One Up on Wall Street (1989)
🟡 39
Doesn't clear Lynch's growth-at-a-reasonable-price bar
Key question
Is the growth worth the price?
Fact → Principle → Simulation
Benjamin Graham
Security Analysis (1934) / The Intelligent Investor (1949)
🟡 36
Fails most of Graham's defensive criteria
Key question
Where is my margin of safety?
Fact → Principle → Simulation
Jesse Livermore
Reminiscences of a Stock Operator (1923) / How to Trade in Stocks (1940)
🔴 31
Negative trend — against Livermore's core rule of trading with the trend
Key question
What is the price telling me right now?
Fact → Principle → Simulation
Benjamin Graham (Enterprising Investor)
The Intelligent Investor (1949) — the Enterprising Investor chapters
🔴 31
Not statistically cheap enough for the Enterprising Investor's looser safety bar
Key question
Is the stock statistically cheap enough to justify the extra risk?
Fact → Principle → Simulation
Based on the last 281 trading days, calculated from real price data. Click an indicator for details and a chart.
🟡 Indicators are mixed — no clear bias (4 bullish · 4 bearish · 3 neutral)
A market-structure read based purely on real price and volume data — not full classic Wyckoff schematic identification (Phase A-E), but a quantitative analysis of what can reliably be computed: trading ranges, "effort vs. result", volume within the range, and Spring/Upthrust detection.
The stock is in a clear downtrend with no defined trading range in the period examined.
High confidence
The Wyckoff Method, developed by Richard Wyckoff in the early 20th century, reads the balance of supply and demand through price and volume, based on the premise that large investors ("smart money") quietly accumulate shares before rallies and quietly distribute them before declines. The read here is based solely on real price and volume data — full, precise identification of classic Wyckoff patterns (such as Phases A-E) requires human chart-reading experience and judgment, so this is an approximate algorithmic read, not a substitute for professional analysis. This should not be considered investment advice.
Gross Margin
41.7%
Operating Margin
20.0%
Net Margin
15.5%
EBITDA Margin
20.0%
ROE
19.9%
ROA
14.5%
ROIC
—
EPS
$4.82
Cash
—
Total Debt
$0
Current Ratio
3.36
Debt/Equity
0.00
Total dividend per share paid each year, over the last 5 years.
| Ex-Dividend Date | Amount per Share |
|---|---|
| 28.8.2026 | $0.440 |
| 22.5.2026 | $0.400 |
| 21.5.2026 | $0.400 |
| 27.2.2026 | $0.400 |
| 26.2.2026 | $0.400 |
| 21.11.2025 | $0.400 |
| 20.11.2025 | $0.400 |
| 22.8.2025 | $0.400 |
| 21.8.2025 | $0.400 |
| 23.5.2025 | $0.340 |
| 22.5.2025 | $0.340 |
| 28.2.2025 | $0.340 |
How is Fair Value calculated? →
Current Price
$131.50
Estimated Fair Value (DCF)
$125.89
Model estimate — not a price target. Highly sensitive to growth/discount-rate assumptions.
Gap
-4.3%
🔴 Appears expensive relative to estimated value
Year 1 Growth Rate
17.6%
Discount Rate (WACC)
9.0%
Terminal Growth Rate
2.5%
Projection Years
5
| Year | Growth Rate | Projected FCF | Present Value |
|---|---|---|---|
| 1 | 17.6% | $199.52M | $183.05M |
| 2 | 13.8% | $227.10M | $191.15M |
| 3 | 10.0% | $249.92M | $192.98M |
| 4 | 6.3% | $265.60M | $188.15M |
| 5 | 2.5% | $272.24M | $176.93M |
Base FCF (last actual year)
$169.67M
Terminal Value
$4.29B
Present Value of Terminal Value
$2.79B
Enterprise Value
$3.72B
Net Debt
$0
Equity Value
$3.72B
*The DCF model is an estimate based on assumptions — not a guaranteed forecast. You can change the assumptions to examine different scenarios.
Book Value per Share
$24.12
Tangible Book Value per Share (Tangible NAV)
$12.15
Sentiment based on basic keywords (not AI) — 14 positive, 5 neutral, 1 negative out of the last 20 articles.
Yahoo · 21.9.2026
Yahoo · 21.9.2026
Yahoo · 18.9.2026
Yahoo · 16.9.2026
Yahoo · 10.9.2026
Yahoo · 9.9.2026
Yahoo · 8.9.2026
Zacks · 8.9.2026
SeekingAlpha · 7.9.2026
SeekingAlpha · 4.9.2026
Yahoo · 3.9.2026
Zacks · 3.9.2026
Yahoo · 3.9.2026
StockStory · 3.9.2026
SeekingAlpha · 2.9.2026
ChartMill · 31.8.2026
Yahoo · 30.8.2026
MarketBeat · 30.8.2026
SeekingAlpha · 30.8.2026
Yahoo · 29.8.2026
Badger Meter, Inc. (BMI) currently has a StockIQ AI score of 65/100, rated "Moderate". The score is a weighted average across up to 7 categories (technical, fundamental, growth, fair value, news, quality, risk), based on real data only.
BMI currently scores 65/100 (Moderate) across the categories we measure. StockIQ doesn't give buy/sell recommendations — use this as one data point in your own research, not as investment advice.
Per StockIQ's DCF model, BMI's estimated fair value is $125.89, which is 4.3% below the current price of $131.50. This is one valuation model among several signals in the fair-value category, not a price target.
BMI's technical score is 49/100, which currently reads as neutral — based on real price/volume signals (moving averages, RSI, MACD, and more), not a prediction of what happens next.
Based on the real signals StockIQ computed: Operating margin is stable or improving over time; Debt/equity: 0.00; Current ratio: 3.36.
Based on the real signals StockIQ computed: Calmar: -0.09 (3y annualized return -4.8% / max drawdown 55.4%); Price is below the 50-day average; Price is below the 200-day average.
Yes — BMI has a real recorded dividend payment history on StockIQ. See the Dividends section on this page for the actual per-share amounts and dates.
Real transactions by officers and insiders, as reported to the SEC on Form 4 — 3 purchases and 0 sales out of the last 25 filings.
| Name | Transaction Type | Date | Shares | Change | Price |
|---|---|---|---|---|---|
| Callahan Edward F. | Open Market Purchase | 30.7.2026 | 751 | +751 | $135.25 |
| Callahan Edward F. | Open Market Purchase | 30.7.2026 | 1,937 | +751 | $135.25 |
| ADAMS TODD A. | Grant/Award from Employer | 1.7.2026 | 128.05 | +128.05 | $148.38 |
| Liu Xia | Grant/Award from Employer | 1.7.2026 | 128.05 | +128.05 | $148.38 |
| ADAMS TODD A. | Grant/Award from Employer | 1.7.2026 | 17,201 | +128 | $148.38 |
| Liu Xia | Grant/Award from Employer | 1.7.2026 | 4,653 | +128 | $148.38 |
| Liu Xia | Grant/Award from Employer | 1.5.2026 | 131.28 | +131.28 | $152.35 |
| Liu Xia | Grant/Award from Employer | 1.5.2026 | 4,525 | +131 | $152.35 |
| Liu Xia | Grant/Award from Employer | 27.4.2026 | 952 | +952 | $122.96 |
| STERN JAMES F | Grant/Award from Employer | 27.4.2026 | 952 | +952 | $122.96 |
| TELLOCK GLEN E | Grant/Award from Employer | 27.4.2026 | 952 | +952 | $122.96 |
| McGill James W | Grant/Award from Employer | 27.4.2026 | 952 | +952 | $122.96 |
| ADAMS TODD A. | Grant/Award from Employer | 27.4.2026 | 952 | +952 | $122.96 |
| Brooks Henry F | Grant/Award from Employer | 27.4.2026 | 952 | +952 | $122.96 |
| Cook Melanie K. | Grant/Award from Employer | 27.4.2026 | 952 | +952 | $122.96 |
| Myers Tessa M. | Grant/Award from Employer | 27.4.2026 | 952 | +952 | $122.96 |
| TELLOCK GLEN E | Grant/Award from Employer | 27.4.2026 | 8,551 | +952 | $122.96 |
| McGill James W | Grant/Award from Employer | 27.4.2026 | 4,893 | +952 | $122.96 |
| STERN JAMES F | Grant/Award from Employer | 27.4.2026 | 8,551 | +952 | $122.96 |
| ADAMS TODD A. | Grant/Award from Employer | 27.4.2026 | 17,072 | +952 | $122.96 |
| Liu Xia | Grant/Award from Employer | 27.4.2026 | 4,393 | +952 | $122.96 |
| Myers Tessa M. | Grant/Award from Employer | 27.4.2026 | 5,913 | +952 | $122.96 |
| Brooks Henry F | Grant/Award from Employer | 27.4.2026 | 3,237 | +952 | $122.96 |
| Cook Melanie K. | Grant/Award from Employer | 27.4.2026 | 3,237 | +952 | $122.96 |
| Wrocklage Robert | Open Market Purchase | 23.4.2026 | 1,000 | +1,000 | $122.35 |
Official FINRA data — the number of shares open in short positions, plus daily short-sale activity.
4,451,641 shares short as of 2026-08-31 · vs. 4,121,432 on 2026-07-31
Official biweekly report (FINRA Rule 4560) — no real higher-frequency data exists for this metric.
73.5% of trading volume this week was short selling, vs. 75.8% the prior week
Based on daily short-sale volume (Reg SHO) — a different metric from the open short interest above: this is daily trading volume, not an open position, so it updates weekly rather than biweekly.
Full breakdown of every data type and its source: Data Sources · Methodology